Latest News & Features
Americas
Janssen, a subsidiary of Johnson & Johnson, has dropped a lawsuit against Samsung's biopharmaceutical arm Samsung Bioepis. 15 November 2017
Americas
Excision BioTherapeutics has become the first company to secure exclusive licences from the University of California, Berkeley for “newly discovered” CRISPR gene editors. 15 November 2017
Big Pharma
Swiss-type second medical use patents can be infringed if a generic producer could have reasonably foreseen that its product would be used intentionally for the claimed use, according to the Supreme Court of the Netherlands. 14 November 2017
Americas
The US Court of Appeals for the Federal Circuit has reversed its findings in Life Technologies v Promega, nine months after the US Supreme Court limited overseas patent infringement. 14 November 2017
Americas
The National System for the Management of Genetic Heritage (SisGen) has been officially launched in Brazil. 14 November 2017
Americas
On November 7, the House Judiciary Committee’s subcommittee on IP took part in the “Sovereign Immunity and the Intellectual Property System” hearing. 13 November 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a lower court’s ruling that two Sanofi-owned patents are not invalid as obvious. 10 November 2017
Americas
Sovereign immunity has been used to harm the IP system in recent years, according to Bob Goodlatte, chairman of the House Judiciary Committee. 9 November 2017
Big Pharma
The Danish Maritime and Commercial High Court has invalidated a supplementary protection certificate (SPC) owned by Gilead. 9 November 2017
Big Pharma
Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High Court. 8 November 2017